Hong Kong – Global Superconnector for Life & Health Enterprises

Hong Kong is a fast-track hub for life sciences, bridging Mainland China with global markets. Backed by a strong R&D talent pool, a world-class healthcare system, and sustained government investment in innovation, the city is also a leading biotech fundraising centre. With fast clinical trials and regulatory enhancements designed to streamline drug and medical device registration, faster clinical trials are helping companies translate ideas into real-world impact more quickly. Join global pharmaceutical and diagnostics leaders, investors and industry experts to explore key policies, investment trends.